13 November 2023
Cancers | Highly Cited Special Issues on Cancer Drug Development in 2022


We are pleased to invite you to read the highly cited Special Issues in 2022 in Cancers (ISSN: 2072-6694) on cancer drug development. We hope this announcement will provide useful information for this field.

The Special Issues list is as follows:

New Diagnostic and Therapeutic Tools Against Multidrug Resistant Tumors
Edited by Prof. Dr. Chiara Riganti, Dr. M. Helena Vasconcelos and Prof. Dr. Catherine Passirani
Viewed by 38700+ | Cited by 160+
Tumor Models and Drug Targeting In Vitro
Edited by Dr. Sascha Kopp and Dr. Marcus Krüger
Viewed by 18700+ | Cited by 30+
The Roles of microRNAs in Cancer Aggressiveness and Drug Resistance
Edited by Dr. Bi-Dar Wang and Prof. Dr. Luciane R Cavalli
Viewed by 20900+ | Cited by 80+
Cancer Stem Cells (CSCs) in Drug Resistance and Their Therapeutic Implications in Cancer Treatment
Edited by Dr. Peter Van Veldhuizen
Viewed by 18000+ | Cited by 50+
Recent Advances in Drug Therapy for Glioblastoma
Edited by Dr. Juan Manuel Sepúlveda-Sánchez
Viewed by 17000+ | Cited by 30+
microRNA and Oxidative Drugs in Cancer Therapy and Prevention
Edited by Prof. Dr. Alberto Izzotti and Prof. Dr. Ming You
Viewed by 17300+ | Cited by 30+

You are welcome to view all the Special Issues and submit relevant papers to the journal Cancers. If you have any questions, you can contact the Editorial Office via cancers@mdpi.com.

Cancers Editorial Office

Back to TopTop